3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Pain, Postoperative
4
Hot Flashes
3
Pain
2
post laminectomy syndrome
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Prostatic Neoplasms
1
Peritoneal Cancer
1
Pancreatic Neoplasms
1
Neuroma
1
Neuralgia
1
Malignant Neoplasms of Female Genital Organs
1
Lung Neoplasms
1
Leiomyoma
1
Kidney Neoplasms
1
Intestinal Diseases
1
Inflammatory Bowel Diseases
1
Ileus
1
Hyperparathyroidism
1
Graves Disease
1
Goiter, Nodular
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Failed Back Surgery Syndrome
1
Diverticulitis
1
Digestive System Diseases
1
Crohn Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Certolizumab Pegol
3
MEDI2070
2
Infliximab
2
secukinumab
1
golimumab
1
Vaccines
1
Saline Solution
1
Papillomavirus Vaccines
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Herpes Zoster Vaccine
1
Calcium Dobesilate
1
Calcitriol
1
Bupivacaine
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Crohn Disease
×
Bupivacaine
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts